Diabetes
Comparable Efficacy of Generic and Brand-Name Drugs for Chronic Conditions Shown in Study
Comparable Efficacy of Generic and Brand-Name Drugs for Chronic Conditions Shown in Study
Although generic versions of prescription medications can be a cheaper alternative for patients, many perceive generics as less effective and less safe than their brand-name counterparts.
Read More >>
Glucometers Help Patients Manage Diabetes
Liraglutide Patent Litigation Case Settled
Study Yields Positive Results for Type 2 Diabetes Injectable Prescription
'Siri, Did I Take My Medications Today?'
Company Introduces Authorized Generic Insulin at Lower Cost
Approvals Sought for Use of Fast-Acting Insulin Aspart in Children
First Mobile App for Insulin Management Released
View more articles >>
Clinical Trials
Parents of Young Adults With Type 1 Diabetes: An Exploratory Study
The Skills, Confidence & Preparedness Index (SCPI)
Introducing CGM at Type 1 Diabetes Diagnosis
Using Pharmacogenetics to Improve Treatment in Early-onset Diabetes
TeLIPro Health Program - Active With Diabetes
Multimedia: Videos
March 8 Pharmacy Week in Review: Walgreens Launches Pharmacy Service for Patients with Cancer, Price Reduction in Diabetes Medication
March 8 Pharmacy Week in Review: Walgreens Launches Pharmacy Service for Patients with Cancer, Price Reduction in Diabetes Medication
Defining and Obtaining Optimal Glycemic Control
Defining and Obtaining Optimal Glycemic Control
T2D Treatment Guidelines: GLP-1 Agonists
T2D Treatment Guidelines: GLP-1 Agonists
Rationale for GLP-1 Therapy in T2D
Rationale for GLP-1 Therapy in T2D